+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID07104058

Study on Using Fibroblast Activation Protein PETCT to Detect Minimal Residual Disease and Its Impact on Recurrence of IgG4-Related Disease

Led by Luo Yaping · Updated on 2025-08-05

46

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether tiny residual lesions detected by a new imaging technology called fibroblast activation protein PETCT 68Ga-FAPI PETCT are linked to the return of IgG4-related disease IgG4-RD in patients who have achieved complete remission after treatment. This study focuses on patients with IgG4-RD who have shown no active disease on standard PET scans after receiving glucocorticoids and immunosuppressant therapy. The goal is to better understand the role of minimal residual disease MRD in disease recurrence. After enrollment, all participants undergo 68Ga-FAPI PETCT screening to detect MRD. Based on results, patients are divided into two groups those without MRD negative on 68Ga-FAPI PETCT who stop treatment and are followed observationally, and those with MRD positive on 68Ga-FAPI PETCT. Patients with MRD are then randomly assigned to either continue low-dose glucocorticoids with or without immunosuppressants or to stop treatment and be observed. The study includes an 18-month follow-up period with clinical assessments every three months to monitor for disease relapse. Participants will have regular clinical evaluations to assess disease activity during the 18-month follow-up. Researchers will observe the recurrence rate of IgG4-RD as the primary outcome. The study uses an online system for randomization, with outcome assessors blinded to group assignments. Participants will be monitored closely to document any relapse, and their treatment status will be adjusted according to the study group.

CONDITIONS

Brief Title

A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD

Research Team

Y

Yaping Luo, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here